Syntax Bio, a synthetic biology company programming the next generation of cell therapies, has published new research in ...
News-Medical.Net on MSN
CRISPR-based Cellgorithm technology ushers in a new era of cell programming
Syntax Bio, a synthetic biology company programming the next generation of cell therapies, today announced the publication of ...
Industrialized, small batch, and individual RNA therapeutics become practical with “in-a-box” manufacturing technology.
From enzymes and lipid nanoparticles to large-scale process design, four global innovators redefine RNA-based medicine development and delivery.
Spatial RNA medicine combines transcriptomics and RNA therapeutics, mapping gene expression in tissues to enhance precision ...
David Baker's lab at the University of Washington is announcing two major leaps in the field of AI-powered protein design.
Conference League cards follow a similar upgrade path to UCL and UEL players but only have to win two games instead of three. Women's Champions League cards also only need two wins to upgrade, but ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback